Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
0.9451
-0.0130 (-1.35%)
Aug 14, 2025, 11:10 AM - Market open
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $18.11 million as of August 14, 2025. Its market cap has increased by 7.94% in one year.
Market Cap
18.11M
Enterprise Value
7.55M
1-Year Change
7.94%
Ranking
Category
Stock Price
$0.95
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $18.11M, a decrease of -97.13%. That is a compound annual growth rate of -55.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 18.36M | -46.21% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
| Mar 17, 2021 | 631.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 596.88B |
| Johnson & Johnson | 419.51B |
| AbbVie | 358.96B |
| UnitedHealth Group | 245.80B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 226.21B |